 | • レポートコード：MRC2-11QY04792 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は遅発性ジスキネジアのグローバル市場について調査・分析したレポートです。種類別（ドーパミン枯渇薬、GABA受容体アゴニスト薬、抗コリン薬）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別遅発性ジスキネジアの競争状況、市場シェア ・世界の遅発性ジスキネジア市場：種類別市場規模 2015年-2020年（ドーパミン枯渇薬、GABA受容体アゴニスト薬、抗コリン薬） ・世界の遅発性ジスキネジア市場：種類別市場規模予測 2021年-2026年（ドーパミン枯渇薬、GABA受容体アゴニスト薬、抗コリン薬） ・世界の遅発性ジスキネジア市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界の遅発性ジスキネジア市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米の遅発性ジスキネジア市場分析：米国、カナダ ・ヨーロッパの遅発性ジスキネジア市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの遅発性ジスキネジア市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の遅発性ジスキネジア市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの遅発性ジスキネジア市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bausch Health、Neurocrine Biosciences、Teva Pharmaceuticals Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
Market Analysis and Insights: Global Tardive Dyskinesia Market
The global Tardive Dyskinesia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tardive Dyskinesia Scope and Market Size
Tardive Dyskinesia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tardive Dyskinesia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bausch Health
Neurocrine Biosciences
Teva Pharmaceuticals Industries
…
Market segment by Type, the product can be split into
Dopamine-Depleting Medications
GABA Receptor Agonist Medications
Anticholinergic Medications
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tardive Dyskinesia Revenue
1.4 Market by Type
1.4.1 Global Tardive Dyskinesia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dopamine-Depleting Medications
1.4.3 GABA Receptor Agonist Medications
1.4.4 Anticholinergic Medications
1.5 Market by Application
1.5.1 Global Tardive Dyskinesia Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Market Perspective (2015-2026)
2.2 Global Tardive Dyskinesia Growth Trends by Regions
2.2.1 Tardive Dyskinesia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tardive Dyskinesia Historic Market Share by Regions (2015-2020)
2.2.3 Tardive Dyskinesia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tardive Dyskinesia Market Growth Strategy
2.3.6 Primary Interviews with Key Tardive Dyskinesia Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia Players by Market Size
3.1.1 Global Top Tardive Dyskinesia Players by Revenue (2015-2020)
3.1.2 Global Tardive Dyskinesia Revenue Market Share by Players (2015-2020)
3.1.3 Global Tardive Dyskinesia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tardive Dyskinesia Market Concentration Ratio
3.2.1 Global Tardive Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Revenue in 2019
3.3 Tardive Dyskinesia Key Players Head office and Area Served
3.4 Key Players Tardive Dyskinesia Product Solution and Service
3.5 Date of Enter into Tardive Dyskinesia Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tardive Dyskinesia Historic Market Size by Type (2015-2020)
4.2 Global Tardive Dyskinesia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tardive Dyskinesia Market Size by Application (2015-2020)
5.2 Global Tardive Dyskinesia Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tardive Dyskinesia Market Size (2015-2020)
6.2 Tardive Dyskinesia Key Players in North America (2019-2020)
6.3 North America Tardive Dyskinesia Market Size by Type (2015-2020)
6.4 North America Tardive Dyskinesia Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tardive Dyskinesia Market Size (2015-2020)
7.2 Tardive Dyskinesia Key Players in Europe (2019-2020)
7.3 Europe Tardive Dyskinesia Market Size by Type (2015-2020)
7.4 Europe Tardive Dyskinesia Market Size by Application (2015-2020)
8 China
8.1 China Tardive Dyskinesia Market Size (2015-2020)
8.2 Tardive Dyskinesia Key Players in China (2019-2020)
8.3 China Tardive Dyskinesia Market Size by Type (2015-2020)
8.4 China Tardive Dyskinesia Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tardive Dyskinesia Market Size (2015-2020)
9.2 Tardive Dyskinesia Key Players in Japan (2019-2020)
9.3 Japan Tardive Dyskinesia Market Size by Type (2015-2020)
9.4 Japan Tardive Dyskinesia Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tardive Dyskinesia Market Size (2015-2020)
10.2 Tardive Dyskinesia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tardive Dyskinesia Market Size by Type (2015-2020)
10.4 Southeast Asia Tardive Dyskinesia Market Size by Application (2015-2020)
11 India
11.1 India Tardive Dyskinesia Market Size (2015-2020)
11.2 Tardive Dyskinesia Key Players in India (2019-2020)
11.3 India Tardive Dyskinesia Market Size by Type (2015-2020)
11.4 India Tardive Dyskinesia Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tardive Dyskinesia Market Size (2015-2020)
12.2 Tardive Dyskinesia Key Players in Central & South America (2019-2020)
12.3 Central & South America Tardive Dyskinesia Market Size by Type (2015-2020)
12.4 Central & South America Tardive Dyskinesia Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bausch Health
13.1.1 Bausch Health Company Details
13.1.2 Bausch Health Business Overview
13.1.3 Bausch Health Tardive Dyskinesia Introduction
13.1.4 Bausch Health Revenue in Tardive Dyskinesia Business (2015-2020))
13.1.5 Bausch Health Recent Development
13.2 Neurocrine Biosciences
13.2.1 Neurocrine Biosciences Company Details
13.2.2 Neurocrine Biosciences Business Overview
13.2.3 Neurocrine Biosciences Tardive Dyskinesia Introduction
13.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2015-2020)
13.2.5 Neurocrine Biosciences Recent Development
13.3 Teva Pharmaceuticals Industries
13.3.1 Teva Pharmaceuticals Industries Company Details
13.3.2 Teva Pharmaceuticals Industries Business Overview
13.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Introduction
13.3.4 Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2015-2020)
13.3.5 Teva Pharmaceuticals Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tardive Dyskinesia Key Market Segments
Table 2. Key Players Covered: Ranking by Tardive Dyskinesia Revenue
Table 3. Ranking of Global Top Tardive Dyskinesia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tardive Dyskinesia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dopamine-Depleting Medications
Table 6. Key Players of GABA Receptor Agonist Medications
Table 7. Key Players of Anticholinergic Medications
Table 8. Global Tardive Dyskinesia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Tardive Dyskinesia Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Tardive Dyskinesia Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Tardive Dyskinesia Market Share by Regions (2015-2020)
Table 12. Global Tardive Dyskinesia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Tardive Dyskinesia Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Tardive Dyskinesia Market Growth Strategy
Table 18. Main Points Interviewed from Key Tardive Dyskinesia Players
Table 19. Global Tardive Dyskinesia Revenue by Players (2015-2020) (Million US$)
Table 20. Global Tardive Dyskinesia Market Share by Players (2015-2020)
Table 21. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia as of 2019)
Table 22. Global Tardive Dyskinesia by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Tardive Dyskinesia Product Solution and Service
Table 25. Date of Enter into Tardive Dyskinesia Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 28. Global Tardive Dyskinesia Market Size Share by Type (2015-2020)
Table 29. Global Tardive Dyskinesia Revenue Market Share by Type (2021-2026)
Table 30. Global Tardive Dyskinesia Market Size Share by Application (2015-2020)
Table 31. Global Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 32. Global Tardive Dyskinesia Market Size Share by Application (2021-2026)
Table 33. North America Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 35. North America Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 36. North America Tardive Dyskinesia Market Share by Type (2015-2020)
Table 37. North America Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 38. North America Tardive Dyskinesia Market Share by Application (2015-2020)
Table 39. Europe Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 41. Europe Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Tardive Dyskinesia Market Share by Type (2015-2020)
Table 43. Europe Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Tardive Dyskinesia Market Share by Application (2015-2020)
Table 45. China Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 46. China Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 47. China Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 48. China Tardive Dyskinesia Market Share by Type (2015-2020)
Table 49. China Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 50. China Tardive Dyskinesia Market Share by Application (2015-2020)
Table 51. Japan Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 53. Japan Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Tardive Dyskinesia Market Share by Type (2015-2020)
Table 55. Japan Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Tardive Dyskinesia Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 59. Southeast Asia Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Tardive Dyskinesia Market Share by Type (2015-2020)
Table 61. Southeast Asia Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Tardive Dyskinesia Market Share by Application (2015-2020)
Table 63. India Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 64. India Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 65. India Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 66. India Tardive Dyskinesia Market Share by Type (2015-2020)
Table 67. India Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 68. India Tardive Dyskinesia Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Tardive Dyskinesia Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Tardive Dyskinesia Market Share (2019-2020)
Table 71. Central & South America Tardive Dyskinesia Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Tardive Dyskinesia Market Share by Type (2015-2020)
Table 73. Central & South America Tardive Dyskinesia Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Tardive Dyskinesia Market Share by Application (2015-2020)
Table 75. Bausch Health Company Details
Table 76. Bausch Health Business Overview
Table 77. Bausch Health Product
Table 78. Bausch Health Revenue in Tardive Dyskinesia Business (2015-2020) (Million US$)
Table 79. Bausch Health Recent Development
Table 80. Neurocrine Biosciences Company Details
Table 81. Neurocrine Biosciences Business Overview
Table 82. Neurocrine Biosciences Product
Table 83. Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2015-2020) (Million US$)
Table 84. Neurocrine Biosciences Recent Development
Table 85. Teva Pharmaceuticals Industries Company Details
Table 86. Teva Pharmaceuticals Industries Business Overview
Table 87. Teva Pharmaceuticals Industries Product
Table 88. Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2015-2020) (Million US$)
Table 89. Teva Pharmaceuticals Industries Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia Market Share by Type: 2020 VS 2026
Figure 2. Dopamine-Depleting Medications Features
Figure 3. GABA Receptor Agonist Medications Features
Figure 4. Anticholinergic Medications Features
Figure 5. Global Tardive Dyskinesia Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Tardive Dyskinesia Report Years Considered
Figure 10. Global Tardive Dyskinesia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Tardive Dyskinesia Market Share by Regions: 2020 VS 2026
Figure 12. Global Tardive Dyskinesia Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Tardive Dyskinesia Market Share by Players in 2019
Figure 15. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Revenue in 2019
Figure 17. North America Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Tardive Dyskinesia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
原発性線毛機能不全の世界市場（～2026年） Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube…- 長時間作用型注射剤（LAI）の世界市場（～2026年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…
- GABA受容体アゴニスト薬の世界市場（～2026年） Market Analysis and Insights: Global GABA Receptor Agonist Drug Market The global GABA Receptor Agonist Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global GABA Receptor Agonist Drug Scope and Market Size GABA Recepto…
- 動物用風味付医薬品の世界市場（～2026年） Flavored Veterinary Medications are the medicines available in different flavors for the diagnosis, treatment and prevention of diseases in animals or birds. Technological advancement, innovation, increasing demand of flavored medications by pet owners, increasing pet health awareness, less expensiv…
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…